Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.
Included in Horizon account
The China veterinary injectables market outlook generated a revenue of USD 795.1 million in 2025 and is expected to reach USD 1,635.7 million by 2033.
| Market revenue in 2025 | USD 795.1 million |
| Market revenue in 2033 | USD 1,635.7 million |
| Growth rate | 9.5% (CAGR from 2026 to 2033) |
| Largest segment | Small Molecules/Conventional Drugs |
| Fastest growing segment | Biosimilars |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecules/Conventional Drugs, Biologics, Biosimilars |
No credit card required*
Publish Date: Sep 09, 2026
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CEVA Inc | View profile | 424 | 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 | www.ceva-dsp.com |
| Vetoquinol SA | View profile | 2,483 | Magny-Vernois, BP 189, Lure cedex, France, 70204 | www.vetoquinol.com |
| Zoetis | View profile | 10001+ | Parsippany, New Jersey, United States, North America | www.zoetis.com |
| Bimeda | View profile | 1001-5000 | Dublin, Dublin, Ireland, Europe | www.bimeda.com/ |
| Elanco | View profile | 10001+ | Greenfield, Indiana, United States, North America | www.elanco.com |
| Merck & Co., Inc. | View profile | - | - | - |
| Boehringer Ingelheim International GmbH | View profile | - | - | - |
| Phibro Animal Health | View profile | 1001-5000 | Teaneck, New Jersey, United States, North America | www.pahc.com/ |
| Virbac | View profile | - | - | - |
| Dechra | View profile | - | Shrewsbury, Shropshire, United Kingdom, Europe | www.dechra.co.uk |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Injectables Market Outlook will help companies and investors design strategic landscapes.
Small Molecules/Conventional Drugs was the largest segment with a revenue share of 66.53% in 2025.
Horizon Databook has segmented the China veterinary injectables market based on small molecules/conventional drugs, biologics, biosimilars covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the China Veterinary Injectables Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Veterinary Injectables Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
